Skip to content

A Clinical study to evaluate the effect of two drugs GUDUCHYADI KSHEERAPAKA and VAYASTHAPANA GANA KSHEERAPAKA in the patients with PERIMENOPAUSAL SYMPTOMS

A Randomized Comparative Clinical study to evaluate the effect of GUDUCHYADI KSHEERAPAKA and VAYASTHAPANA GANA KSHEERAPAKA in the management of RAJO NIVRUTTI LAXANAS with special reference to PERIMENOPAUSAL SYMPTOMS

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045653
Enrollment
100
Registered
2022-09-19
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N959- Unspecified menopausal and perimenopausal disorder

Interventions

None listed

Sponsors

DR LAVANYA HOLEYANNAVAR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Greene Climacteric Scale ââ?¬â?? Score more than 5 2.Serum estradiol levels less than 25 pg/ml 3.FSH more than 30ml U/ml 4.Women of age between 40-55 years. 5.Subjects presenting with Perimenopausal symptoms

Exclusion criteria

Exclusion criteria: 1.Subjects who had undergone hysterectomy. 2.Subjects with systemic illness interfering with the study

Design outcomes

Primary

MeasureTime frame
TO GET RELIEF FROM PERI MENOPAUSAL SYMPTOMS AND IMPROVING THE GENERAL HEALTH CONDITION OF A WOMENTimepoint: 8 WEEKS

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactDR G RAMADEVI

Rajiv Gandhi University of Health Science Bangalore

dr.ramadevig@gmail.com9449937158

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 27, 2026